Cellular Senescence-Associated Gene Expression in Circulating CD4+, CD8+, CD19+ Lymphocytes of HNSCC Patients: Associations with Clinical Parameters.

Senescence-associated secretory phenotype (SASP) signaling, along with key markers such as P16INK4a/CDKN2A and LMNB1, has not been systematically studied in circulating lymphocyte subsets in head and neck squamous cell carcinoma (HNSCC). This study aimed to evaluate SASP-related genes and senescence markers in peripheral CD4+, CD8+, and CD19+ cells and assess their clinical relevance. Expression of IL-6, IL-1β, TNFα, CXCL1, P16INK4a/CDKN2A, and LMNB1 was measured by RT-qPCR in sorted lymphocytes from 58 HNSCC patients at baseline, 31 post-treatment, and 13 controls. Statistical analyses included nonparametric tests, correlation analyses, and survival models (Kaplan-Meier, Cox regression). In the results, LMNB1 was significantly upregulated in all lymphocyte subsets of HNSCC patients. IL-6, CXCL1, and IL-1β were elevated in CD4+ T cells. A coordinated co-expression network involving IL-6, CXCL1, IL-1β, P16INK4a/CDKN2A, and LMNB1 was observed. Clinically, IL-6 in CD8+ T cells was associated with higher nodal stage and worse survival, while CXCL1 in CD19+ B cells independently predicted survival. No differences were found between pre- and post-treatment samples. Circulating lymphocytes in HNSCC display coordinated expression of selected senescence-associated genes, with IL-6 and CXCL1 as candidate prognostic biomarkers linked to tumor progression that warrant further validation.